Milestone Pharmaceuticals Inc.

MIST

—

Advanced chart & tools →

Milestone Pharmaceuticals Inc.MIST

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.75

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$238,000

Net income

$-63.06M

Net margin

-26495.0%

Gross margin

—

Dividends & financials

Milestone Pharmaceuticals Inc. (MIST) reported revenue of $238,000 and net income of $-63.06M, or $-0.75 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.